HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
about
The protein farnesyltransferase regulates HDAC6 activity in a microtubule-dependent mannerPKC alpha regulates Sendai virus-mediated interferon induction through HDAC6 and β-cateninHDAC Inhibitors as Epigenetic Regulators of the Immune System: Impacts on Cancer Therapy and Inflammatory DiseasesColon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemopreventionHistone deacetylase 6 plays a role as a distinct regulator of diverse cellular processesdsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effectsThe promise and perils of HDAC inhibitors in neurodegenerationHDAC6 is overexpressed in cystic cholangiocytes and its inhibition reduces cystogenesisHistone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.Anaplastic Thyroid Carcinoma: Current Treatments and Potential New Therapeutic Options with Emphasis on TfR1/CD71.HDAC6 regulates LPS-tolerance in astrocytes.A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia.Subcellular localization of class II HDAs in Arabidopsis thaliana: nucleocytoplasmic shuttling of HDA15 is driven by light.MicroRNA roles in beta-catenin pathway.Genome-wide analysis of HMGA2 transcription factor binding sites by ChIP on chip in gastric carcinoma cells.The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis.Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substratesThe renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.C/EBPα Short-Activating RNA Suppresses Metastasis of Hepatocellular Carcinoma through Inhibiting EGFR/β-Catenin Signaling Mediated EMT.Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity.HDAC6 inhibitors modulate Lys49 acetylation and membrane localization of β-catenin in human iPSC-derived neuronal cellsTreatment of chronic kidney diseases with histone deacetylase inhibitors.Targeting Histone Deacetylases in Diseases: Where Are We?RhoB upregulation leads to either apoptosis or cytostasis through differential target selection.Epigenetics and autosomal dominant polycystic kidney disease.New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometryBoth stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts.The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapiesRegulation of CD133 by HDAC6 promotes β-catenin signaling to suppress cancer cell differentiationInhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivatorsRequirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition.HDAC6 and ovarian cancer.Oncogenic K-ras confers SAHA resistance by up-regulating HDAC6 and c-myc expression.Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney diseaseCigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability.Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2.Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors.HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies.The tale of protein lysine acetylation in the cytoplasm.
P2860
Q24312194-3BDD5727-8642-489E-8D83-98B82DC90BDEQ24338826-1F34DB04-5DCE-46D1-AB1C-5EE395416D24Q26739120-F3E76431-3BEB-4D9D-B7AC-B5C61C9D54A0Q26782809-65A72A0A-8DC7-45D0-9034-B63B4AA916ABQ26830233-27C1DF01-4ACF-492C-850B-92182558BD36Q26864048-7EAEE3ED-498F-40AE-B6D0-3B801D689BB1Q28087539-61BCC013-0FC1-41CC-AAC6-9E65FA2E4F71Q28572123-603BA1D2-177F-4C35-94A0-6E73D358DF9DQ33913080-116E0DBB-E0FD-40E0-826C-0A680A4F7A19Q33914771-F7FAD882-547B-4554-AF2B-71EF08DD7481Q34055727-01005EA9-E383-4CDC-9926-5DFE1DB56E9DQ34100430-DA0433EB-6DC0-4730-8EBE-718231FB44D0Q34170297-A71A9D2A-E6BA-4A05-8214-A5352A2838D3Q34202840-B56EEF92-AF33-4745-B8DB-53FE7BD202A5Q34247211-E33A2E95-8ACB-48E2-B801-580B66B665D2Q34296908-099E9429-164D-4DB9-82AE-6A724D1D2BDFQ34460624-4DDC4A2F-4BA5-4419-8E7C-66631F96D570Q34518270-BCF6981F-E340-45F6-95C6-26EB04974F37Q34521048-590A348C-D32A-4DEB-8684-51B1151844D7Q34854958-EF9A389F-5B67-45C2-A5BF-D26901D57598Q35213084-39AA4E25-C1B3-4065-BB16-0761E9C14168Q35545347-3D7399FA-A471-46EC-A6CE-BC04654F4246Q35821728-61778304-AB0A-49C0-B55C-1F8482E83AB7Q36027160-2E802247-6EB8-412D-8E22-B42754EF5F39Q36146066-C867C194-AE0B-4EF9-8159-B643C1930548Q36298070-32EECBFC-5771-43F5-A980-47D425AF6989Q36486683-47FC22D1-54CF-4206-9C69-2CC6CC940A6FQ36515479-821F3432-435A-40E3-B22D-8F131D295975Q36664232-17A0F4F7-BBEA-4082-817B-00FAF1A85A41Q36756601-34B09E73-484A-4016-B2DB-FD16A3E21EDCQ36777948-61BE3B20-DE2C-4976-9C64-23E100643CCBQ36913610-49186ED3-4920-4F99-BE78-831830A09A4CQ36962880-EF67ADA1-DD05-4CB8-923E-608476F849CDQ37017182-873A9247-B930-4A58-8E68-ED69C5666D2DQ37088228-86E2B635-AD71-4ADD-8F80-EB05C6368420Q37409603-B264FCE7-64FA-44B8-961B-C93D76999756Q37445946-47FFFBB2-9115-4F34-A17F-9E135AB67300Q37706060-D26DD8CA-D0B6-40A4-8DAA-1CA22724B47DQ37738242-52E58EF6-06D9-420A-B061-03D035075EC9Q37820143-640A05BD-20CD-4892-A976-E98B07B805A4
P2860
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@ast
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en-gb
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@nl
type
label
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@ast
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en-gb
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@nl
prefLabel
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@ast
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en-gb
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@nl
P2093
P2860
P921
P3181
P356
P1476
HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization
@en
P2093
Michael J Comb
Roberto D Polakiewicz
Tso-Pang Yao
Xiaowu Zhang
P2860
P304
P3181
P356
10.1074/JBC.C700185200
P407
P577
2008-05-09T00:00:00Z